Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Investment in securities market are subject to market risks. Read all the related documents carefully before investing

India's Third Giant Leap
Discover the Best Category of Stocks to Ride this Mega
Opportunity at Our Upcoming Special Event




**Important: We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
**By submitting your email address, you also sign up for Profit Hunter, a daily newsletter from Equitymaster
covering exciting investing ideas and opportunities in India.


AD

SURYA PHARMA Share Price   (SUPH)



Here is the latest stock price and chart of SURYA PHARMA. For more details, see the SURYA PHARMA company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report. Since such stocks interest you, here's a proven approach to making penny stock investments.

REFRESH
Live BSE Quotes Sep 14, 2015 (Close)
Price (Rs)0.16 Open (Rs) 0.16 High (Rs) 0.16 Low (Rs) 0.16
% Change-5.88 Volume 234,695 Value (Rs) 37,551 52-Week H/L 1.49 / 0.15
Live NSE Quotes Aug 14, 2023 3:16:16 PM
Price (Rs)95.00 Open (Rs) 95.00 High (Rs) 95.00 Low (Rs) 95.00
% Change-5.00 Volume 100 Value (Rs) 9,500 52-Week H/L 1.85 / 0.80
Change
1 Day
-5.88%
1 Month
-15.79%
3 Months
-5.88%
1 Year
-87.69%
5 Years (CAGR)*
-38.44%

* Compound Annual Growth Rate

Valuation
EPS (Rs)* 12.76 P/E Ratio (x) 0.01 Market Cap (Rs m) 32.44 P/BV (x) - Dividend Yield (%) 0.00
  *Trailing 12 months earnings, excluding extraordinary / exceptional items. BSE Sensex | CNX Nifty

Charts
Loading...
 
     
 S&P BSE SENSEX 
PERIOD
Advanced Charts new
Charts by TradingView

As of December 2015, promoter pledging in stands at 26.18%. To know more, check out the latest shareholding pattern of .



FAQs on SURYA PHARMA

What is the SURYA PHARMA share price today?

The last traded price of SURYA PHARMA was Rs 0.2 on the BSE, down 5.9% over the previous close. On the NSE, SURYA PHARMA last traded price was down 5.0% at Rs 95.0.

What is the market cap of SURYA PHARMA?

The current market capitalisation of SURYA PHARMA stands at Rs 32 m.

What is the Earnings per share (EPS) of SURYA PHARMA?

SURYA PHARMA had an EPS of Rs 12.8 in the latest financial year. In the most recent quarter, the company declared an EPS of Rs -0.8.

What is the PE Ratio and PB Ratio of SURYA PHARMA?

At the current price of Rs 0.2, SURYA PHARMA trades at a PE ratio of 0.01 while its PB ratio stands at .

What is the Dividend Yield of SURYA PHARMA?

For the financial year 2013, SURYA PHARMA declared dividend amounting to Rs 0.0 per share. At the current price of Rs 0.2, this results in a dividend yield of 0.0%.

Which are the top pharmaceuticals companies in India by marketcap?

Based on marketcap, these are the top pharmaceuticals companies in India:

You can see the full list of pharmaceuticals stocks ranked by marketcap here.

Also, here's one of our more popular screens related to marketcap: India's Biggest Companies by Marketcap.

Which are the biggest pharmaceuticals companies in India by sales?

Based on sales, these are the top pharmaceuticals companies in India:

You can see the full list of pharmaceuticals stocks.

Curious to know which Indian companies are growing their sales at a faster rate than their peers? Check out India's Fastest Growing Companies by Sales.

Which are the biggest pharmaceuticals companies in India by net profit?

Based on net profit, these are the top pharmaceuticals companies in India:

You can see the full list of pharmaceuticals stocks.

In case you are wondering which company logs in the biggest net profit margin in India, check this out: High Profit Margin Companies in India.


Today's Market

Sensex Today Hits Record High | Nifty Ends Near 21,000 | IT and Banking Stocks Rally Sensex Today Hits Record High | Nifty Ends Near 21,000 | IT and Banking Stocks Rally(Closing)

Indian share markets defied weak Asian cues and traded on a positive note throughout the session.